[{"address1": "116 Huntington Avenue", "address2": "Suite 703", "city": "Boston", "state": "MA", "zip": "02116", "country": "United States", "phone": "617 468 4219", "website": "https://www.bicara.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. The company's lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.", "fullTimeEmployees": 55, "companyOfficers": [{"maxAge": 1, "name": "Ms. Claire  Mazumdar Clemon M.B.A., Ph.D.", "age": 34, "title": "CEO & Director", "yearBorn": 1990, "fiscalYear": 2024, "totalPay": 829800, "exercisedValue": 0, "unexercisedValue": 5023506}, {"maxAge": 1, "name": "Mr. Ryan  Cohlhepp Pharm.D.", "age": 47, "title": "President, COO & Director", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 825750, "exercisedValue": 0, "unexercisedValue": 2526259}, {"maxAge": 1, "name": "Mr. Ivan  Hyep M.B.A.", "age": 39, "title": "Chief Financial Officer", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 915375, "exercisedValue": 0, "unexercisedValue": 1986752}, {"maxAge": 1, "name": "Ms. Lara S. Meisner J.D.", "age": 51, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rachel  Salazar", "title": "SVP of R&D Strategy and Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sathish  Hasige Ph.D.", "title": "Senior VP and Head of Technical Operations & Supply Chain", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Raben M.D.", "age": 60, "title": "Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angela  Windt", "title": "VP & Head of Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeltje  Schulten M.B.A., M.D.", "title": "Senior Vice President of Clinical & Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jean-Paul  Rodrique", "title": "Senior VP & Global Head of Quality Assurance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 11.89, "open": 11.89, "dayLow": 11.79, "dayHigh": 13.29, "regularMarketPreviousClose": 11.89, "regularMarketOpen": 11.89, "regularMarketDayLow": 11.79, "regularMarketDayHigh": 13.29, "payoutRatio": 0.0, "forwardPE": -8.204968, "volume": 205050, "regularMarketVolume": 205050, "averageVolume": 542037, "averageVolume10days": 637320, "averageDailyVolume10Day": 637320, "bid": 12.99, "ask": 13.39, "bidSize": 1, "askSize": 1, "marketCap": 720423232, "fiftyTwoWeekLow": 8.91, "fiftyTwoWeekHigh": 28.09, "fiftyDayAverage": 13.0772, "twoHundredDayAverage": 17.061203, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 159309344, "profitMargins": 0.0, "floatShares": 31270218, "sharesOutstanding": 54536200, "sharesShort": 5391114, "sharesShortPriorMonth": 5046885, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.098900005, "heldPercentInsiders": 0.116459996, "heldPercentInstitutions": 0.86203, "shortRatio": 10.79, "shortPercentOfFloat": 0.1547, "impliedSharesOutstanding": 60261000, "bookValue": 9.035, "priceToBook": 1.4620919, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -67995000, "trailingEps": -4.05, "forwardEps": -1.61, "enterpriseToEbitda": -1.935, "52WeekChange": -0.49209738, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 13.21, "targetHighPrice": 48.0, "targetLowPrice": 8.0, "targetMeanPrice": 33.2, "targetMedianPrice": 36.0, "recommendationMean": 1.85714, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 489711008, "totalCashPerShare": 8.982, "ebitda": -82333000, "totalDebt": 738000, "quickRatio": 27.221, "currentRatio": 27.934, "debtToEquity": 0.15, "returnOnAssets": -0.13843, "returnOnEquity": -0.19143, "freeCashflow": -53717124, "operatingCashflow": -74751000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "BCAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Bicara Therapeutics Inc.", "longName": "Bicara Therapeutics Inc.", "corporateActions": [], "regularMarketTime": 1746724605, "exchange": "NGM", "messageBoardId": "finmb_674698236", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "epsTrailingTwelveMonths": -4.05, "epsForward": -1.61, "epsCurrentYear": -1.642, "priceEpsCurrentYear": -8.045067, "fiftyDayAverageChange": 0.1328001, "fiftyDayAverageChangePercent": 0.010155087, "twoHundredDayAverageChange": -3.851203, "twoHundredDayAverageChangePercent": -0.22572869, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-09-13", "averageAnalystRating": "1.9 - Buy", "cryptoTradeable": false, "regularMarketChange": 1.3199997, "regularMarketDayRange": "11.79 - 13.29", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 542037, "regularMarketChangePercent": 11.101764, "regularMarketPrice": 13.21, "marketState": "REGULAR", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1726234200000, "fiftyTwoWeekLowChange": 4.3, "fiftyTwoWeekLowChangePercent": 0.48260385, "fiftyTwoWeekRange": "8.91 - 28.09", "fiftyTwoWeekHighChange": -14.88, "fiftyTwoWeekHighChangePercent": -0.5297259, "fiftyTwoWeekChangePercent": -49.20974, "earningsTimestamp": 1743075049, "earningsTimestampStart": 1743075049, "earningsTimestampEnd": 1743075049, "isEarningsDateEstimate": false, "displayName": "Bicara Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]